Scanlan Sean F. (CIK 1856371) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-11). Recent activity: Sell TMCI (401 shares), Sell TMCI (1,396 shares), Buy TMCI (16,875 shares), Buy TMCI (53,500 shares), Buy TMCI (262,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-11 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 401 | $0 |
| 2026-03-11 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 1,396 | $0 |
| 2026-02-11 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 16,875 | $17,719 |
| 2026-01-23 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 53,500 | $38,520 |
| 2026-01-23 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 262,500 | $0 |
| 2025-10-28 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 208 | $0 |
| 2025-08-12 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 9,814 | $0 |
| 2025-07-22 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 33,437 | $24,075 |
| 2025-03-19 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 50,000 | $52,500 |
| 2025-03-19 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 50,000 | $398,500 |
| 2025-03-11 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 401 | $0 |
| 2025-03-11 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Sell | 1,396 | $0 |
| 2025-01-24 | TREACE MEDICAL CONCEPTS, INC. (TMCI) | Chief Innovation Officer | Buy | 140,625 | $0 |
Source: SEC Form 4 filings · as of 2026-03-11